MedTrace Logo

Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy

NCT04615715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 582

Last updated 2026-04-03

No results posted yet for this study

Summary

This study will evaluate whether a brief prenatal clinic-based cytomegalovirus (CMV) risk-reduction behavioral intervention will prevent maternal CMV infections during pregnancy in women.

Conditions

  • Maternal Cytomegalovirus Infections
  • Cytomegalovirus Congenital

Interventions

BEHAVIORAL

CMV Risk-Reduction Intervention

CMV Risk-Reduction Intervention

BEHAVIORAL

Stress Reduction Messaging

Stress Reduction Messaging

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Karen B Fowler · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-11
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615715 on ClinicalTrials.gov